Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD026 with Metformin in Type 2 Diabetes
NCT02434744Phase 2Completed
- Sponsor
- Response Pharmaceuticals
- Start
- Apr 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KD026 in type 2 diabetes mellitus (T2DM), sponsored by Response Pharmaceuticals. Started Apr 2015; status: completed.
02
Drugs
KD026
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02434744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434744.